Cambridge Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $39M | Buy |
246,319
+1,588
| +0.6% | +$253K | 1.47% | 21 |
|
|
2023
Q4 | $38.4M | Sell |
244,731
-1,280
| -0.5% | -$196K | 1.6% | 16 |
|
|
2023
Q3 | $38.3M | Buy |
246,011
+1,451
| +0.6% | +$239K | 1.77% | 14 |
|
|
2023
Q2 | $40.5M | Sell |
244,560
-16,080
| -6% | -$2.6M | 1.83% | 13 |
|
|
2023
Q1 | $40.4M | Sell |
260,640
-8,685
| -3% | -$1.4M | 1.93% | 10 |
|
|
2022
Q4 | $47.6M | Sell |
269,325
-4,929
| -2% | -$851K | 2.13% | 8 |
|
|
2022
Q3 | $44.8M | Sell |
274,254
-3,121
| -1% | -$528K | 2.12% | 6 |
|
|
2022
Q2 | $49.2M | Sell |
277,375
-1,695
| -0.6% | -$302K | 2.16% | 7 |
|
|
2022
Q1 | $49.5M | Sell |
279,070
-2,069
| -0.7% | -$352K | 1.73% | 11 |
|
|
2021
Q4 | $48.1M | Buy |
281,139
+35,271
| +14% | +$5.77M | 1.55% | 14 |
|
|
2021
Q3 | $39.7M | Buy |
245,868
+2
| +0% | +$341 | 1.5% | 20 |
|
|
2021
Q2 | $40.5M | Sell |
245,866
-447
| -0.2% | -$74K | 1.52% | 17 |
|
|
2021
Q1 | $40.5M | Buy |
246,313
+13,034
| +6% | +$2.11M | 1.65% | 15 |
|
|
2020
Q4 | $36.7M | Sell |
233,279
-3,931
| -2% | -$580K | 1.74% | 15 |
|
|
2020
Q3 | $35.3M | Buy |
237,210
+1,657
| +0.7% | +$245K | 1.82% | 13 |
|
|
2020
Q2 | $34.7M | Buy |
235,553
+1,877
| +0.8% | +$274K | 1.82% | 14 |
|
|
2020
Q1 | $30.6M | Sell |
233,676
-4,159
| -2% | -$590K | 2.1% | 10 |
|
|
2019
Q4 | $34.7M | Sell |
237,835
-3,236
| -1% | -$439K | 1.83% | 13 |
|
|
2019
Q3 | $31.2M | Sell |
241,071
-24,509
| -9% | -$3.23M | 1.81% | 14 |
|
|
2019
Q2 | $37M | Sell |
265,580
-16,642
| -6% | -$2.3M | 2.15% | 9 |
|
|
2019
Q1 | $39.5M | Sell |
282,222
-3,749
| -1% | -$502K | 2.36% | 8 |
|
|
2018
Q4 | $36.9M | Sell |
285,971
-5,607
| -2% | -$782K | 2.54% | 5 |
|
|
2018
Q3 | $40.3M | Sell |
291,578
-4,093
| -1% | -$544K | 2.32% | 8 |
|
|
2018
Q2 | $35.9M | Sell |
295,671
-4,594
| -2% | -$573K | 2.23% | 9 |
|
|
2018
Q1 | $38.5M | Sell |
300,265
-1,532
| -0.5% | -$207K | 2.46% | 6 |
|
|
2017
Q4 | $42.2M | Buy |
301,797
+1,584
| +0.5% | +$221K | 2.66% | 4 |
|
|
2017
Q3 | $39M | Buy |
300,213
+5,790
| +2% | +$768K | 2.62% | 4 |
|
|
2017
Q2 | $39M | Sell |
294,423
-16,837
| -5% | -$2.15M | 2.69% | 2 |
|
|
2017
Q1 | $38.8M | Sell |
311,260
-4,516
| -1% | -$539K | 2.57% | 2 |
|
|
2016
Q4 | $36.4M | Buy |
315,776
+4,306
| +1% | +$497K | 2.56% | 5 |
|
|
2016
Q3 | $36.8M | Buy |
311,470
+4,482
| +1% | +$544K | 2.69% | 2 |
|
|
2016
Q2 | $37.2M | Buy |
306,988
+9,161
| +3% | +$1.04M | 2.85% | 3 |
|
|
2016
Q1 | $32.2M | Buy |
297,827
+8,179
| +3% | +$847K | 2.64% | 3 |
|
|
2015
Q4 | $29.8M | Buy |
289,648
+2,701
| +0.9% | +$272K | 2.44% | 5 |
|
|
2015
Q3 | $26.8M | Sell |
286,947
-5,432
| -2% | -$525K | 2.35% | 7 |
|
|
2015
Q2 | $28.5M | Sell |
292,379
-3,624
| -1% | -$363K | 2.36% | 5 |
|
|
2015
Q1 | $29.8M | Sell |
296,003
-44,572
| -13% | -$4.53M | 2.5% | 4 |
|
|
2014
Q4 | $35.6M | Buy |
340,575
+5,971
| +2% | +$629K | 3.09% | 2 |
|
|
2014
Q3 | $35.7M | Buy |
334,604
+1,176
| +0.4% | +$122K | 3.17% | 2 |
|
|
2014
Q2 | $34.9M | Buy |
333,428
+3,670
| +1% | +$371K | 3.02% | 2 |
|
|
2014
Q1 | $32.4M | Sell |
329,758
-243
| -0.1% | -$22.5K | 2.98% | 3 |
|
|
2013
Q4 | $30.2M | Sell |
330,001
-369
| -0.1% | -$34K | 2.81% | 4 |
|
|
2013
Q3 | $28.6M | Sell |
330,370
-1,814
| -0.5% | -$163K | 2.85% | 3 |
|
|
2013
Q2 | $28.5M | Buy |
+332,184
| New | +$28.2M | 2.95% | 3 |
|
Other funds holding JNJ
Cambridge Trust's JNJ Position: Q1 2024 in Review
Cambridge Trust increased its Johnson & Johnson (JNJ) stake by 0.65% in Q1 2024, buying an estimated $253K and bringing the position to 246,319 shares worth $39M. The position accounts for 1.47% of the portfolio, ranked #21.
Cambridge Trust first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $49.5M in Q1 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.
- Cambridge Trust held 246,319 shares of Johnson & Johnson worth $39M as of Q1 2024.
- Cambridge Trust bought 1,588 Johnson & Johnson shares in Q1 2024, an estimated $253K.
- Johnson & Johnson made up 1.47% of Cambridge Trust's portfolio in Q1 2024, its #21 holding.
- Cambridge Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
- Cambridge Trust's Johnson & Johnson position peaked at $49.5M in Q1 2022.
- 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.